Back to results
US 2014/0179907 A1Published application
Anti-cd40 antibodies
AssigneeBoehringer Ingelheim International GmbH
InventorsRachel Rebecca BARRETT, Scott Ronald BRODEUR, Keith CANADA, Tobias LITZENBURGER, Sanjaya SINGH
Life of this patent
Estimating the term…
Abstract
The present invention relates to new humanized antagonistic anti-CD40 antibodies and therapeutic and diagnostic methods and compositions for using the same.
Claims5
1-14. (canceled)
An isolated polynucleotide encoding a heavy chain variable region amino acid sequence and a light chain variable region amino acid sequence, wherein the heavy chain variable region amino acid sequence comprises any of SEQ ID NO:
- 1 to 4, SEQ ID NO:27, SEQ ID NO:28, SEQ ID NO:
- 29, SEQ ID NO:30, SEQ ID NO:32, SEQ ID NO:33, SEQ ID NO:34, SEQ ID NO:35, SEQ ID NO:37, SEQ ID NO:38, SEQ ID NO:39, SEQ ID NO:
- 40, SEQ ID NO:
- 42, SEQ ID NO:
- 44, SEQ ID NO:
- 46, SEQ ID NO:
- 48, SEQ ID. NO. 50, SEQ ID NO:
- 53, SEQ ID NO:
- 57, SEQ ID NO:
- 58, SEQ ID NO:
- 59, SEQ ID NO:
- 60, SEQ ID NO:
- 61, SEQ ID NO:
- 62, SEQ ID NO:
- 63, SEQ ID NO:
- 64, SEQ ID NO:
- 65, SEQ ID NO:
- 66, SEQ ID NO:
- 67, SEQ ID NO:
- 68, SEQ ID NO:
- 69, SEQ ID NO:
- 70, SEQ ID NO:
- 71, SEQ ID NO:
- 72, or SEQ ID NO:
- 73;
- and light chain variable region amino acid sequence comprises any of SEQ ID NO:
- 5 to SEQ ID NO:8, SEQ ID NO:26, SEQ ID NO:31, SEQ ID NO:36, SEQ ID NO:41, SEQ ID NO:43, SEQ ID NO:45, SEQ ID NO:47, SEQ ID NO:49, SEQ ID NO:50, SEQ ID NO:51, SEQ ID NO:52, SEQ ID NO:54, SEQ ID NO:55, SEQ ID NO:56, SEQ ID NO:74, SEQ ID NO:75, or SEQ ID NO:76.
24 more elements
Dependencies are inferred from the claim text.